blood pressure
play

Blood Pressure Control to Reduce your risk of a second event - PowerPoint PPT Presentation

Reducing your Risk of Heart Disease Webinar Series Blood Pressure Control to Reduce your risk of a second event Created with an educational grant from: Part 3 May 2, 2019 Presenters Andrea Baer, MS Director of Patient Advocacy and


  1. Reducing your Risk of Heart Disease Webinar Series Blood Pressure Control to Reduce your risk of a second event Created with an educational grant from: Part 3 May 2, 2019

  2. Presenters • Andrea Baer, MS – Director of Patient Advocacy and Program Management, Mended Hearts and Mended Little Hearts. Andrea is also a mom to a 10 year old son with Congenital Heart Disease. • Dharmesh Patel, MD MBBS ( London) FACC FACP FASPC FNLA – Dr. Patel is a practicing cardiologist at the Stern Cardiovascular Foundation. He holds board certification's in Internal Medicine, Cardiology, Hypertension, Echocardiography, Nuclear Cardiology, and is a Diplomate of Clinical Lipidology and Vascular Interpretation. Special interest include Preventative Cardiology , Hypertension, Lipidology. He is involved in the Stern Cardiovascular Foundation, Specialist Clinical Hypertension, American Society of Hypertension, President of AfPA ( Alliance for Patient Access), Past American Heart Association President, Past Chairman of Medicine Baptist Desoto Hospital, Board of AHA Southeast America • Marlyn Taylor – Western Regional Director Elect, Mended Hearts. Marlyn has served as his chapter’s president for six years and as secretary for two. He has been an assistant regional director for 8 years and has helped start five new chapters in the Washington and Oregon areas during this time.

  3. About • Mended Hearts is the largest peer-to-peer support Mended network in the world. Hearts • Mended Hearts mission is: “To inspire hope and improve the quality of life of heart patients and their families through on-going peer-to- peer support, education, and advocacy”. • 285 Chapters across the country serving over 460 hospitals.

  4. About the ASPC • The American Society for Preventive Cardiology mission statement is: “To promote the prevention of cardiovascular disease, advocate for the preservation of cardiovascular health, and disseminate high- quality, evidence-based information through the education of healthcare clinicians and their patients”.

  5. Dharmesh Patel, MD MBBS ( London) FACC FACP FASPC FNLA Stern Cardiovascular Foundation Specialist Clinical Hypertension, American Society of Hypertension

  6. Robert M. Carey et al. JACC 2018;72:1278-1293 2018 American College of Cardiology Foundation

  7. Categories of BP in Adults* BP Category SBP DBP Normal <120 mm Hg and <80 mm Hg 120 – 129 mm Elevated and <80 mm Hg Hg Hypertension 130 – 139 mm 80 – 89 mm Stage 1 or Hg Hg ≥140 mm Hg ≥90 mm Hg Stage 2 or *Individuals with SBP and DBP in 2 categories should be designated to the higher BP category. BP indicates blood pressure (based on an average of ≥2 careful readings obtained on ≥2 occasions, as detailed in DBP, diastolic blood pressure; and SBP systolic blood pressure.

  8. Causes of Secondary Hypertension With Clinical Indications Common causes Renal parenchymal disease Renovascular disease Primary aldosteronism Obstructive sleep apnea Drug or alcohol induced Uncommon causes Pheochromocytoma/paraganglioma Cushing ’ s syndrome Hypothyroidism Hyperthyroidism Aortic coarctation (undiagnosed or repaired) Primary hyperparathyroidism Congenital adrenal hyperplasia Mineralocorticoid excess syndromes other than primary aldosteronism Acromegaly

  9. Best Proven Nonpharmacological Interventions for Prevention and Treatment of Hypertension* Nonpharmacologi Dose Approximate Impact on SBP -cal Intervention Hypertension Normotension Weight/body fat Best goal is ideal body weight, but aim Weight loss -5 mm Hg -2/3 mm Hg for at least a 1-kg reduction in body weight for most adults who are overweight. Expect about 1 mm Hg for every 1-kg reduction in body weight. Healthy diet DASH dietary Consume a diet rich in fruits, -11 mm Hg -3 mm Hg pattern vegetables, whole grains, and low-fat dairy products, with reduced content of saturated and total fat. Reduced intake Dietary sodium Optimal goal is <1500 mg/d, but aim -5/6 mm Hg -2/3 mm Hg of dietary for at least a 1000-mg/d reduction in sodium most adults. Dietary Enhanced Aim for 3500 – 5000 mg/d, preferably -4/5 mm Hg -2 mm Hg potassium intake of by consumption of a diet rich in dietary potassium. potassium *Type, dose, and expected impact on BP in adults with a normal BP and with hypertension. DASH indicates Dietary Approaches to Stop Hypertension; and SBP, systolic blood pressure. Resources: Your Guide to Lowering Your Blood Pressure With DASH — How Do I Make the DASH? Available at: https://www.nhlbi.nih.gov/health/resources/heart/hbp-dash-how-to. Top 10 Dash Diet Tips. Available at: http://dashdiet.org/dash_diet_tips.asp

  10. Best Proven Nonpharmacological Interventions for Prevention and Treatment of Hypertension* (cont.) Nonpharmacologica Dose Approximate Impact on SBP Hypertension Normotension l Intervention Physical Aerobic ● 90 – 150 min/wk -5/8 mm Hg -2/4 mm Hg activity ● 65% – 75% heart rate reserve Dynamic resistance ● 90 – 150 min/wk -4 mm Hg -2 mm Hg ● 50% – 80% 1 rep maximum ● 6 exercises, 3 sets/exercise, 10 repetitions/set Isometric resistance ● 4 × 2 min (hand grip), 1 min rest -5 mm Hg -4 mm Hg between exercises, 30% – 40% maximum voluntary contraction, 3 sessions/wk ● 8 – 10 wk Moderation Alcohol In individuals who drink alcohol, -4 mm Hg -3 mm in alcohol consumption reduce alcohol† to: intake ● Men: ≤2 drinks daily ● Women: ≤1 drink daily *Type, dose, and expected impact on BP in adults with a normal BP and with hypertension. †In the United States, one “standard” drink contains roughly 14 g of pure alcohol, which is typically found in 12 oz of regul ar beer (usually about 5% alcohol), 5 oz of wine (usually about 12% alcohol), and 1.5 oz of distilled spirits (usually about 40% alcohol).

  11. Basic and Optional Laboratory Tests for Primary Hypertension Fasting blood glucose* Basic testing Complete blood count Lipid profile Serum creatinine with eGFR* Serum sodium, potassium, calcium* Thyroid-stimulating hormone Urinalysis Electrocardiogram Optional testing Echocardiogram Uric acid Urinary albumin to creatinine ratio *May be included in a comprehensive metabolic panel. eGFR indicates estimated glomerular filtration rate.

  12. BP Thresholds for and Goals of Pharmacological Therapy in Patients With Hypertension According to Clinical Conditions BP BP Goal, Clinical Condition(s) Threshold, mm Hg mm Hg General Clinical CVD or 10- year ASCVD risk ≥10% ≥130/80 <130/80 ≥140/90 No clinical CVD and 10-year ASCVD risk <10% <130/80 Older persons (≥65 years of age; noninstitutionalized, ≥130 (SBP) <130 (SBP) ambulatory, community-living adults) Specific comorbidities ≥130/80 Diabetes mellitus <130/80 ≥130/80 Chronic kidney disease <130/80 ≥130/80 Chronic kidney disease after renal transplantation <130/80 ≥130/80 Heart failure <130/80 ≥130/80 Stable ischemic heart disease <130/80 ≥140/90 Secondary stroke prevention <130/80 ≥130/80 Secondary stroke prevention (lacunar) <130/80 ≥130/80 Peripheral arterial disease <130/80 ASCVD indicates atherosclerotic cardiovascular disease; BP, blood pressure; CVD, cardiovascular disease; and SBP, systolic blood pressure.

  13. Clinician’s Sequential Flow Chart for the Management of Hypertension Clinician ’ s Sequential Flow Chart for the Management of Hypertension Measure office BP accurately Detect white coat hypertension or masked hypertension by using ABPM and HBPM Evaluate for secondary hypertension Identify target organ damage Introduce lifestyle interventions Identify and discuss treatment goals Use ASCVD risk estimation to guide BP threshold for drug therapy Align treatment options with comorbidities Account for age, race, ethnicity, sex, and special circumstances in antihypertensive treatment Initiate antihypertensive pharmacological therapy Insure appropriate follow-up Use team-based care Connect patient to clinician via telehealth Detect and reverse nonadherence Detect white coat effect or masked uncontrolled hypertension Use health information technology for remote monitoring and self-monitoring of BP ASCVD indicates atherosclerotic cardiovascular disease; BP, blood pressure; CVD, cardiovascular disease; and SBP, systolic blood pressure.

  14. MARLYN TAYLOR C M B O L Y O N O T D S R P O T R L E O L S R S I U Y N R G E

  15. A t Places you might E y e Get your blood Pressure E x a m taking. Dentist Office Drug Store Doctors Office, Annual Check UP Hospital Lobby

  16. D HOW 0 N I A FOUND T OUT I THAT N G I HAD B HIGH L O BLOOD O PRESSURE D

  17. FIRST LINE OF DEFENSE M E D I C A T I O N

  18. SECOND LINE OF DEFENSE D I E T

  19. THIRD LINE OF DEFENSE EXERCISE

  20. Forth LINE OF DEFENSE Relaxation

  21. FOR BEST RESULTS PUT IT ALL TOGEATHER THANK YOU!

  22. Next Webinar in the Series: • May 16 th 2019 • 12:00 PM ET • Preventive Exercise and Physical Activity

  23. Thank you to our Sponsor: www.mendedhearts.org www.aspconline.org 1-888-HEART-99

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend